SAC Capital in the dock for insider trading: could it happen here?
By Robin Barclay
Last week’s announcement that the US Department of Justice (DoJ) has charged a company, SAC Capital, with criminal insider trading has left the global hedge fund and banking industry reeling. Hot on the heels of the FCA corporate LIBOR scandals, the decision to charge a company with insider trading in the US raises the question: could the FCA charge a hedge fund or bank with the crime of insider dealing here?
At first blush the answer is ‘no’, owing to the fact that the offence of insider dealing, as created by s.52 of the Criminal Justice Act 1993, applies to individuals and not companies. On this basis, so far as principal offenders go, hedge funds and banks cannot be indicted because that was Parliament’s intention.
What about their corporate criminal liability as accessories or secondary parties? S.8 of the Accessories and Abettors Act 1861 provides: ‘Whosoever shall aid, abet, counsel or procure the commission of any indictable offence, whether the offence be at common law or by virtue of any act passed or to be passed, shall be liable to be tried, indicted and punished as a principal offender.’ In short, as insider dealing is an offence by virtue of the Criminal Justice Act, in an appropriate factual situation a company may be liable as a secondary party for insider dealing committed by an employee…
If you are registered and logged in to the site, click on the link below to read the rest of the Outer Temple Chambers briefing. If not, please register or sign in with your details below.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Outer Temple Chambers
News from The Lawyer
Briefings from Outer Temple Chambers
The Supreme Court on 11 March 2015 handed down a unanimous judgment that confirms that the Bolam test does not apply to a doctor’s duty to warn patients of the risks of treatment.
An important judgment has been handed down that deals with the remedies available to members of the IBM Project Waltz scheme.